IMCC Stock Overview
Engages in breeding, growing, and supply of medical cannabis products in Israel and Germany.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
IM Cannabis Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$3.97 |
| 52 Week High | CA$10.68 |
| 52 Week Low | CA$1.44 |
| Beta | 1.72 |
| 11 Month Change | 27.24% |
| 3 Month Change | -23.95% |
| 1 Year Change | -31.08% |
| 33 Year Change | -98.61% |
| 5 Year Change | n/a |
| Change since IPO | -97.37% |
Recent News & Updates
Recent updates
A Piece Of The Puzzle Missing From IM Cannabis Corp.'s (CSE:IMCC) Share Price
Jul 30
Potential Upside For IM Cannabis Corp. (CSE:IMCC) Not Without Risk
Jul 19Health Check: How Prudently Does IM Cannabis (CSE:IMCC) Use Debt?
Dec 24Don't Ignore The Fact That This Insider Just Sold Some Shares In IM Cannabis Corp. (CSE:IMCC)
Feb 05
What Percentage Of IM Cannabis Corp. (CSE:IMCC) Shares Do Insiders Own?
Jan 08Shareholder Returns
| IMCC | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | -2.7% | -6.0% | 0.9% |
| 1Y | -31.1% | 37.6% | 15.8% |
Return vs Industry: IMCC underperformed the Canadian Pharmaceuticals industry which returned 37.6% over the past year.
Return vs Market: IMCC underperformed the Canadian Market which returned 15.8% over the past year.
Price Volatility
| IMCC volatility | |
|---|---|
| IMCC Average Weekly Movement | 19.3% |
| Pharmaceuticals Industry Average Movement | 10.3% |
| Market Average Movement | 8.0% |
| 10% most volatile stocks in CA Market | 16.6% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: IMCC's share price has been volatile over the past 3 months.
Volatility Over Time: IMCC's weekly volatility has decreased from 31% to 19% over the past year, but is still higher than 75% of Canadian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 95 | Oren Shuster | imcannabis.com |
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers medical cannabis dried flowers; and full-spectrum, strain-specific cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands. The company serves medical patients.
IM Cannabis Corp. Fundamentals Summary
| IMCC fundamental statistics | |
|---|---|
| Market cap | CA$8.86m |
| Earnings (TTM) | -CA$14.09m |
| Revenue (TTM) | CA$49.88m |
0.2x
P/S Ratio-0.6x
P/E RatioIs IMCC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IMCC income statement (TTM) | |
|---|---|
| Revenue | CA$49.88m |
| Cost of Revenue | CA$43.77m |
| Gross Profit | CA$6.11m |
| Other Expenses | CA$20.20m |
| Earnings | -CA$14.09m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -6.31 |
| Gross Margin | 12.25% |
| Net Profit Margin | -28.25% |
| Debt/Equity Ratio | 276.4% |
How did IMCC perform over the long term?
See historical performance and comparison